INTRODUCTION:Prolonged exercise requires increased utilization of blood glucose and adjustment of glucoregulatory hormones. Estrogen can reduce hepatic gluconeogenesis which could affect insulin concentrations. Amylin is co-secreted with insulin and controls influx of glucose into the blood. PURPOSE: To determine the effect of menstrual cycle stage on glucose, leptin, and pancreatic hormone responses to prolonged (90 min) exercise. METHODS:Five healthy, eumenorrheic women (24.6 ± 5.1 years; 67.4 ± 1 kg) were monitored for 3 months to determine menstrual cycle length. Subjects completed a preliminary session to determine exercise workloads and, in a fasted condition, completed two randomized 90-min treadmill exercise trials at 60 % VO2max during the early follicular (EFX) and mid-luteal phase (MLX) of their menstrual cycle. Blood samples were analyzed for glucose, insulin, C-peptide, amylin, glucagon, leptin, and cortisol concentrations at rest (-30 and 0 min), during exercise (18, 36, 54, 72, and 90 min) and after 20 min of recovery. RESULTS: No changes in amylin, leptin, or cortisol occurred for EFX and MLX trials. A significant (p < 0.05) time effect occurred for glucose, insulin, and glucagon with reduced insulin across the exercise trial and increases in glucose and glucagon later in the trial, but there were no differences between the EFX and MLX trials. CONCLUSIONS: Menstrual cycle stage does not affect glucose, insulin, C-peptide, amylin, glucagon, cortisol, and leptin responses to prolonged exercise; however, the exercise reduces insulin and increases glucose and glucagon concentrations. This is the first study to determine acute effects of exercise on amylin and other glucoregulatory hormone responses in women.
RCT Entities:
INTRODUCTION: Prolonged exercise requires increased utilization of blood glucose and adjustment of glucoregulatory hormones. Estrogen can reduce hepatic gluconeogenesis which could affect insulin concentrations. Amylin is co-secreted with insulin and controls influx of glucose into the blood. PURPOSE: To determine the effect of menstrual cycle stage on glucose, leptin, and pancreatic hormone responses to prolonged (90 min) exercise. METHODS: Five healthy, eumenorrheic women (24.6 ± 5.1 years; 67.4 ± 1 kg) were monitored for 3 months to determine menstrual cycle length. Subjects completed a preliminary session to determine exercise workloads and, in a fasted condition, completed two randomized 90-min treadmill exercise trials at 60 % VO2max during the early follicular (EFX) and mid-luteal phase (MLX) of their menstrual cycle. Blood samples were analyzed for glucose, insulin, C-peptide, amylin, glucagon, leptin, and cortisol concentrations at rest (-30 and 0 min), during exercise (18, 36, 54, 72, and 90 min) and after 20 min of recovery. RESULTS: No changes in amylin, leptin, or cortisol occurred for EFX and MLX trials. A significant (p < 0.05) time effect occurred for glucose, insulin, and glucagon with reduced insulin across the exercise trial and increases in glucose and glucagon later in the trial, but there were no differences between the EFX and MLX trials. CONCLUSIONS: Menstrual cycle stage does not affect glucose, insulin, C-peptide, amylin, glucagon, cortisol, and leptin responses to prolonged exercise; however, the exercise reduces insulin and increases glucose and glucagon concentrations. This is the first study to determine acute effects of exercise on amylin and other glucoregulatory hormone responses in women.
Authors: R R Kraemer; R J Heleniak; J L Tryniecki; G R Kraemer; N J Okazaki; V D Castracane Journal: Med Sci Sports Exerc Date: 1995-06 Impact factor: 5.411
Authors: Robert R Kraemer; Michelle R Francois; Kiran Sehgal; Bovorn Sirikul; Roldán A Valverde; V Daniel Castracane Journal: Med Sci Sports Exerc Date: 2011-08 Impact factor: 5.411
Authors: J Wahren; K Ekberg; J Johansson; M Henriksson; A Pramanik; B L Johansson; R Rigler; H Jörnvall Journal: Am J Physiol Endocrinol Metab Date: 2000-05 Impact factor: 4.310
Authors: Michaela C Devries; Mazen J Hamadeh; Stuart M Phillips; Mark A Tarnopolsky Journal: Am J Physiol Regul Integr Comp Physiol Date: 2006-05-11 Impact factor: 3.619
Authors: R R Kraemer; E O Acevedo; L B Synovitz; R J Durand; L G Johnson; E Petrella; M S Fineman; T Gimpel; V D Castracane Journal: Metabolism Date: 2002-05 Impact factor: 8.694
Authors: Christopher T V Swain; Ann E Drummond; Leonessa Boing; Roger L Milne; Dallas R English; Kristy A Brown; Eline H van Roekel; Suzanne C Dixon-Suen; Michael J Lynch; Melissa M Moore; Tom R Gaunt; Richard M Martin; Sarah J Lewis; Brigid M Lynch Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-10-20 Impact factor: 4.254
Authors: Brett A Gordon; Caroline J Taylor; Jarrod E Church; Stephen D Cousins Journal: Int J Environ Res Public Health Date: 2021-01-02 Impact factor: 3.390